CAMK2D and central nervous system cancer: Although there were some studies revealed the cell resistant by CaMK II may be through the Fas pathway, our findings provided a new vision of CAMK2D that may regulate common pathogenesis of schizophrenia and glioma so that the potential treatments of schizophrenia could be found in the glioma pathway, and vice versa.